Ultragenyx $122 million IPO explodes, doubling price in first few hours of trading
January 31, 2014 at 12:16 PM EST
Rare disease drug developer Ultragenyx Pharmaceutical Inc. exploded onto the market Friday, setting its IPO price at $21 but climbing to just short of $48 per share by mid-day trading...